Company: CSTL
Filing Date: 2025-03-28
Form Type: PRE 14A
Source: 0001447362-25-000050
Chunk: 114

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-03-28
Form: PRE 14A
Chunk 114
---
 Incorporation, the affirmative vote of the holders of at least 66 2/3% of the voting power of all of the then-outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class, shall be required to alter, amend or repeal this Article IX.

<div align='center'>* * * *</div>

FOUR: This Certificate of Incorporation has been duly adopted and approved by the Board of Directors and by written consent of the stockholders in accordance with Sections 228, 242 and 245 of the DGCL. and written notice of such action has been given as provided in section 228 of the DGCL.

<div align='center'>[Signature page follows]</div>

In Witness Whereof , Castle Biosciences, Inc. has caused this Amended and Restated Certificate of Incorporation to be signed by its President and Chief Executive Officer this _________ day of _________, 2025.

| Castle Biosciences, Inc.              |
| Derek Maetzold                        |
| President and Chief Executive Officer |

#### 100Castle Biosciences 2025 Proxy Statement
<div align='center'>PRELIMINARY PROXY STATEMENT, SUBJECT TO COMPLETION DATED MARCH 28, 2025

PRELIMINARY PROXY STATEMENT, SUBJECT TO COMPLETION DATED MARCH 28, 2025</div>